P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas

Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors

(2012) Hatice Ozer et al.   Diagnostic Pathology

Ovarian low-grade serous carcinoma: A comprehensive update

(2012) Ivan Diaz-Padilla et al.   GYNECOLOGIC ONCOLOGY

Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas - an immunohistochemical study

(2011) Andreas H Habberstad et al.   Diagnostic Pathology

BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas

(2010) Kwong-Kwok Wong et al.   AMERICAN JOURNAL OF PATHOLOGY

An Immunohistochemical Comparison of P53 and Bcl-2 as Apoptotic and MIB1 as Proliferative Markers in Low-Grade and High-Grade Ovarian Serous Carcinomas

(2010) Suniti K. Mishra et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Ovarian Low-grade and High-grade Serous Carcinoma

(2009) Russell Vang et al.   ADVANCES IN ANATOMIC PATHOLOGY

Defining the Cut Point Between Low-grade and High-grade Ovarian Serous Carcinomas

(2009) Ayse Ayhan et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A case of non-invasive serous adenocarcinoma at unilateral fimbria with spread to the peritoneal/uterine cavity: case report

(2009) Yuki Fukumura et al.   Diagnostic Pathology

Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant

(2009) David M. Gershenson et al.   GYNECOLOGIC ONCOLOGY

The significance of Epstein Barr Virus (EBV) & DNA Topoisomerase II alpha (DNA-Topo II alpha) immunoreactivity in normal oral mucosa, Oral Epithelial Dysplasia (OED) and Oral Squamous Cell Carcinoma (OSCC)

(2008) Ali A Shamaa et al.   Diagnostic Pathology

Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum

(2008) Kathleen M. Schmeler et al.   GYNECOLOGIC ONCOLOGY